ELEDON PHARMACEUTICALS INC's ticker is ELDN and the CUSIP is 28617K101. A total of 34 filers reported holding ELEDON PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,952 | 0.0% | 2,155 | 0.0% | 0.00% | – |
| Q2 2023 | $2,952 | +147500.0% | 2,155 | +215400.0% | 0.00% | – |
| Q4 2022 | $2 | -99.9% | 1 | -99.9% | 0.00% | – |
| Q3 2022 | $3,000 | -40.0% | 1,133 | -44.2% | 0.00% | – |
| Q2 2022 | $5,000 | -28.6% | 2,032 | +15.8% | 0.00% | – |
| Q1 2022 | $7,000 | -82.1% | 1,754 | -80.0% | 0.00% | – |
| Q4 2021 | $39,000 | -94.2% | 8,771 | -92.0% | 0.00% | – |
| Q3 2021 | $677,000 | -89.9% | 109,456 | -87.1% | 0.00% | -100.0% |
| Q2 2021 | $6,732,000 | +5329.0% | 851,004 | +7235.6% | 0.00% | – |
| Q1 2021 | $124,000 | – | 11,601 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Logos Global Management LP | 1,339,793 | $10,598,000 | 0.89% |
| CM Management, LLC | 75,000 | $593,000 | 0.43% |
| Cormorant Asset Management, LP | 1,415,500 | $11,197,000 | 0.38% |
| BVF INC/IL | 1,113,435 | $8,807,000 | 0.33% |
| Ikarian Capital, LLC | 350,000 | $2,769,000 | 0.22% |
| Woodline Partners LP | 857,445 | $6,782,000 | 0.13% |
| INGALLS & SNYDER LLC | 51,149 | $405,000 | 0.02% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 853,208 | $6,749,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 40,052 | $317,000 | 0.01% |
| Point72 Asset Management, L.P. | 188,690 | $1,493,000 | 0.01% |